ENST00000370228.2:c.*1C>A

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The ENST00000370228.2(TWNK):​c.*1C>A variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.237 in 1,613,746 control chromosomes in the GnomAD database, including 51,641 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.29 ( 7580 hom., cov: 32)
Exomes 𝑓: 0.23 ( 44061 hom. )

Consequence

TWNK
ENST00000370228.2 3_prime_UTR

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 0.952

Publications

29 publications found
Variant links:
Genes affected
TWNK (HGNC:1160): (twinkle mtDNA helicase) This gene encodes a hexameric DNA helicase which unwinds short stretches of double-stranded DNA in the 5' to 3' direction and, along with mitochondrial single-stranded DNA binding protein and mtDNA polymerase gamma, is thought to play a key role in mtDNA replication. The protein localizes to the mitochondrial matrix and mitochondrial nucleoids. Mutations in this gene cause infantile onset spinocerebellar ataxia (IOSCA) and progressive external ophthalmoplegia (PEO) and are also associated with several mitochondrial depletion syndromes. Alternative splicing results in multiple transcript variants encoding distinct isoforms.[provided by RefSeq, Aug 2009]
TWNK Gene-Disease associations (from GenCC):
  • progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 3
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • mitochondrial DNA depletion syndrome 7 (hepatocerebral type)
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae)
  • autosomal dominant progressive external ophthalmoplegia
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • mitochondrial DNA depletion syndrome, hepatocerebrorenal form
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • Perrault syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.81).
BP6
Variant 10-100991026-C-A is Benign according to our data. Variant chr10-100991026-C-A is described in ClinVar as Benign. ClinVar VariationId is 136591.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.528 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TWNKNM_021830.5 linkc.1734+16C>A intron_variant Intron 4 of 4 ENST00000311916.8 NP_068602.2 Q96RR1-1E5KSY5Q9H6V3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TWNKENST00000311916.8 linkc.1734+16C>A intron_variant Intron 4 of 4 1 NM_021830.5 ENSP00000309595.2 Q96RR1-1

Frequencies

GnomAD3 genomes
AF:
0.289
AC:
43985
AN:
151996
Hom.:
7556
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.445
Gnomad AMI
AF:
0.152
Gnomad AMR
AF:
0.303
Gnomad ASJ
AF:
0.139
Gnomad EAS
AF:
0.544
Gnomad SAS
AF:
0.306
Gnomad FIN
AF:
0.174
Gnomad MID
AF:
0.180
Gnomad NFE
AF:
0.200
Gnomad OTH
AF:
0.267
GnomAD2 exomes
AF:
0.274
AC:
68942
AN:
251318
AF XY:
0.266
show subpopulations
Gnomad AFR exome
AF:
0.444
Gnomad AMR exome
AF:
0.374
Gnomad ASJ exome
AF:
0.139
Gnomad EAS exome
AF:
0.550
Gnomad FIN exome
AF:
0.174
Gnomad NFE exome
AF:
0.202
Gnomad OTH exome
AF:
0.246
GnomAD4 exome
AF:
0.231
AC:
337875
AN:
1461632
Hom.:
44061
Cov.:
33
AF XY:
0.231
AC XY:
168143
AN XY:
727116
show subpopulations
African (AFR)
AF:
0.470
AC:
15731
AN:
33476
American (AMR)
AF:
0.365
AC:
16330
AN:
44706
Ashkenazi Jewish (ASJ)
AF:
0.139
AC:
3624
AN:
26136
East Asian (EAS)
AF:
0.554
AC:
21979
AN:
39696
South Asian (SAS)
AF:
0.292
AC:
25160
AN:
86256
European-Finnish (FIN)
AF:
0.179
AC:
9561
AN:
53398
Middle Eastern (MID)
AF:
0.211
AC:
1207
AN:
5732
European-Non Finnish (NFE)
AF:
0.206
AC:
229358
AN:
1111842
Other (OTH)
AF:
0.247
AC:
14925
AN:
60390
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.466
Heterozygous variant carriers
0
14375
28750
43124
57499
71874
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
8400
16800
25200
33600
42000
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.290
AC:
44056
AN:
152114
Hom.:
7580
Cov.:
32
AF XY:
0.291
AC XY:
21642
AN XY:
74360
show subpopulations
African (AFR)
AF:
0.445
AC:
18458
AN:
41478
American (AMR)
AF:
0.304
AC:
4646
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
0.139
AC:
483
AN:
3470
East Asian (EAS)
AF:
0.544
AC:
2808
AN:
5158
South Asian (SAS)
AF:
0.305
AC:
1471
AN:
4826
European-Finnish (FIN)
AF:
0.174
AC:
1839
AN:
10584
Middle Eastern (MID)
AF:
0.173
AC:
51
AN:
294
European-Non Finnish (NFE)
AF:
0.200
AC:
13595
AN:
67994
Other (OTH)
AF:
0.269
AC:
567
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.494
Heterozygous variant carriers
0
1445
2890
4334
5779
7224
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
430
860
1290
1720
2150
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.205
Hom.:
2813
Bravo
AF:
0.310
Asia WGS
AF:
0.422
AC:
1466
AN:
3478
EpiCase
AF:
0.196
EpiControl
AF:
0.204

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
Jun 30, 2011
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:2
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.81
CADD
Benign
8.0
DANN
Benign
0.69
PhyloP100
0.95
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3740487; hg19: chr10-102750783; COSMIC: COSV54550555; COSMIC: COSV54550555; API